Development of the neurotrophic keratopathy questionnaire: qualitative research

Journal of Patient-Reported Outcomes

Table 2 Clinical Characteristics

Characteristic	Total(N = 14)
Date of Diagnosis (months)
Mean (SD)	28.2 (17.4)
Median [Range]	28.6 (3–80)
Current Mackie Classification, n (%)
Stage I	2 (14.3%)
Stage II	3 (21.4%)
Stage III	9 (64.3%)
Health Conditions, n (%)^a
None	2 (14.3%)
Anxiety	2 (14.3%)
Arthritis	4 (28.6%)
Cancer	3 (21.4%)
COPD	2 (14.3%)
Depression	2 (14.3%)
Diabetes	1 (7.1%)
Hypertension	5 (35.7%)
Multiple sclerosis	1 (7.1%)
Psychosis	1 (7.1%)
Other^b	6 (42.9%)

^aNot mutually exclusive
^bOther health conditions include: “asthma, stroke” (n = 1), “IBS, GERD, sleep problems” (n = 1), “LDL” (n = 1), “sarcoidosis” (n = 1), “hyperthyroidism, mitral valve regurgitation” (n = 1), and “mal de debarquement syndrome, CKD stage III, vertigo” (n = 1)
Abbreviations: CKD Chronic kidney disease, COPD Chronic obstructive pulmonary disease, GERD Gastroesophageal reflux disease, IBS Inflammatory bowel syndrome, LDL Low-density lipoprotein, SD Standard deviation